"Does ashwagandha work" is really three separate questions wearing one trench coat: does it lower stress and cortisol, does it help sleep, and does it improve cognition? The honest answer is different for each, and treating them as one claim is where a lot of marketing goes wrong. Here is what randomized human trials actually report, graded the same way we grade every ingredient on this site.

The stress and cortisol evidence — the strongest part of the case

This is where ashwagandha's human evidence is most consistent. Multiple randomized, placebo-controlled trials of standardized root extract — mostly 60-day studies at 240–600 mg per day — report reduced perceived-stress scores and lower serum cortisol versus placebo in adults reporting chronic stress.

  • Chandrasekhar et al. (2012) — 300 mg twice daily of a high-concentration full-spectrum root extract reduced stress and anxiety scores and serum cortisol over 60 days versus placebo in adults with a history of chronic stress.
  • Salve et al. (2019) — 300 mg/day (as two 250 mg capsules) of KSM-66 reduced perceived stress scale scores and serum cortisol over 8 weeks in healthy adults versus placebo.
  • Lopresti et al. (2019) — 240 mg/day of a standardized extract reduced self-reported stress and serum cortisol, and improved some wellbeing measures, over 8 weeks versus placebo.
  • Pratte et al. (2014), a systematic review, concluded the available randomized trials consistently point toward anxiolytic and stress-reducing effects, while flagging that most trials are still small.

The sleep evidence — promising, secondary

Langade et al. (2019) reported that 300 mg twice daily of standardized root extract improved sleep quality and sleep onset over 8 weeks in adults with insomnia and anxiety, alongside the expected reduction in anxiety scores. This tracks with ashwagandha's calming, non-stimulating profile, but it is a smaller and more specific evidence base than the general stress data, and mostly studied in people who already had sleep or anxiety complaints rather than good sleepers looking for an edge.

The cognition evidence — thinner ground

This is the part of the ashwagandha story that gets stretched furthest by marketing. Direct cognitive-performance trials in healthy adults are smaller, less consistent, and often piggyback on stress-focused studies rather than being designed around cognition as the primary outcome. Any cognitive benefit reported in the literature appears largely downstream of stress and sleep improvement — a calmer, better-rested person often reports feeling sharper — rather than a distinct, direct cognitive mechanism with its own dedicated trial base. That is why the ashwagandha ingredient page on this site grades the stress use case separately from, and higher than, the cognition use case.

What the studies actually used, versus what labels say

Nearly every positive trial above used a specific branded, standardized extract (KSM-66 or Sensoril) at a stated withanolide percentage — not generic "ashwagandha root powder." A product that names the branded extract and standardization is telling you it can plausibly be compared to this research. A product that just says "ashwagandha" with no standardization cannot be meaningfully compared to any of it. See our piece on cited dose versus delivered dose for why that distinction matters more than it looks.

What this evidence doesn't show

  • It doesn't show a same-day or acute effect — every positive trial measured outcomes after weeks of consistent daily use, not a single dose.
  • It doesn't show the effect is unique to ashwagandha versus other studied stress-management approaches — no head-to-head trials against, say, structured breathing or exercise interventions exist in this literature.
  • It doesn't show benefit in people who are not particularly stressed to begin with — most trial participants were selected for elevated baseline stress, so the effect in an already-calm, well-rested person is less established.
  • Several of the highest-quality trials were funded or supported by the extract manufacturer, which does not invalidate the results but is worth knowing when weighing independence of evidence.

How to think about it

For stress and cortisol, and secondarily for sleep, ashwagandha has a genuinely solid — though not enormous — body of randomized human evidence behind it, at specific standardized doses taken consistently for weeks. For direct cognitive enhancement in an already-calm, well-rested person, the evidence is considerably thinner and mostly indirect. "Does it work" depends entirely on which claim you mean.

References

  • Chandrasekhar K, Kapoor J, Anishetty S. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian Journal of Psychological Medicine, 2012;34(3):255–262. PMID: 23439798.
  • Salve J, Pate S, Debnath K, Langade D. "Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study." Cureus, 2019;11(12):e6466. PMID: 32021735.
  • Lopresti AL, Smith SJ, Malvi H, Kodgule R. "An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study." Medicine (Baltimore), 2019;98(37):e17186. PMID: 31517876.
  • Pratte MA, Nanavati KB, Young V, Morley CP. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera)." Journal of Alternative and Complementary Medicine, 2014;20(12):901–908. PMID: 24805805.
  • Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. "Efficacy and Safety of Ashwagandha (Withania Somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study." Cureus, 2019;11(9):e5797. PMID: 31728244.